Topography-biased compound library design: the shape of things to come?
The design and synthesis of quality compound libraries is of critical importance to any pharmaceutical company that relies on high throughput screening efforts for the identification of lead compounds. In this perspective, we use a moment of inertia derived shape analysis to interrogate potential li...
Gespeichert in:
Veröffentlicht in: | Drug discovery today 2007-11, Vol.12 (21), p.948-952 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 952 |
---|---|
container_issue | 21 |
container_start_page | 948 |
container_title | Drug discovery today |
container_volume | 12 |
creator | Akritopoulou-Zanze, Irini Metz, James T. Djuric, Stevan W. |
description | The design and synthesis of quality compound libraries is of critical importance to any pharmaceutical company that relies on high throughput screening efforts for the identification of lead compounds. In this perspective, we use a moment of inertia derived shape analysis to interrogate potential libraries for chemical synthesis. An analysis of known ‘Rule of Five’ compliant drug shapes using this methodology clearly highlights compound libraries that may be reasonably expected, shape wise, to interact with biologically relevant protein active site topography and those that, although being structurally diverse in shape, have little chance of being pharmacologically productive. The use of multicomponent reactions as a means of producing structurally novel, bioactive compounds in a synthetically expeditious manner is also highlighted. |
doi_str_mv | 10.1016/j.drudis.2007.08.017 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68501107</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1359644607003704</els_id><sourcerecordid>20772441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-5f64ffcfac372d112b71f4285dd190e4f59dba9f7dd1c5fbb49c061b079b77243</originalsourceid><addsrcrecordid>eNqFkU2LFDEQhoMo7u7oPxDpk7duU-l8dDwosrirsOBlPYdOUpnJMNNpk25h_70ZZsCbe6oqeKoK3oeQd0A7oCA_7jufVx9LxyhVHR06CuoFuYZBDa0Yevay9r3QreRcXpGbUvaUAtNCviZXoLTuOfTX5P4xzWmbx3n31No4FvSNS8c5rZNvDtHmMT81HkvcTp-aZYdN2Y0zNinUIU7b0izpxOOXN-RVGA8F317qhvy6-_Z4-719-Hn_4_brQ-s4Y0srguQhuDC6XjEPwKyCwNkgvAdNkQehvR11UHV2IljLtaMSLFXaKsV4vyEfznfnnH6vWBZzjMXh4TBOmNZi5CAoAFXPgj1IwSQXz4KMnh7XsDaEn0GXUykZg5lzPNaADFBzUmL25qzEnJQYOpiqpK69v9xf7RH9v6WLgwp8PgNYc_sTMZviIk4OfczoFuNT_P-Hv3ZNnqY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20772441</pqid></control><display><type>article</type><title>Topography-biased compound library design: the shape of things to come?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Akritopoulou-Zanze, Irini ; Metz, James T. ; Djuric, Stevan W.</creator><creatorcontrib>Akritopoulou-Zanze, Irini ; Metz, James T. ; Djuric, Stevan W.</creatorcontrib><description>The design and synthesis of quality compound libraries is of critical importance to any pharmaceutical company that relies on high throughput screening efforts for the identification of lead compounds. In this perspective, we use a moment of inertia derived shape analysis to interrogate potential libraries for chemical synthesis. An analysis of known ‘Rule of Five’ compliant drug shapes using this methodology clearly highlights compound libraries that may be reasonably expected, shape wise, to interact with biologically relevant protein active site topography and those that, although being structurally diverse in shape, have little chance of being pharmacologically productive. The use of multicomponent reactions as a means of producing structurally novel, bioactive compounds in a synthetically expeditious manner is also highlighted.</description><identifier>ISSN: 1359-6446</identifier><identifier>EISSN: 1878-5832</identifier><identifier>DOI: 10.1016/j.drudis.2007.08.017</identifier><identifier>PMID: 17993413</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Chemistry, Pharmaceutical ; Drug Design ; Molecular Conformation</subject><ispartof>Drug discovery today, 2007-11, Vol.12 (21), p.948-952</ispartof><rights>2007 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-5f64ffcfac372d112b71f4285dd190e4f59dba9f7dd1c5fbb49c061b079b77243</citedby><cites>FETCH-LOGICAL-c422t-5f64ffcfac372d112b71f4285dd190e4f59dba9f7dd1c5fbb49c061b079b77243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.drudis.2007.08.017$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17993413$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Akritopoulou-Zanze, Irini</creatorcontrib><creatorcontrib>Metz, James T.</creatorcontrib><creatorcontrib>Djuric, Stevan W.</creatorcontrib><title>Topography-biased compound library design: the shape of things to come?</title><title>Drug discovery today</title><addtitle>Drug Discov Today</addtitle><description>The design and synthesis of quality compound libraries is of critical importance to any pharmaceutical company that relies on high throughput screening efforts for the identification of lead compounds. In this perspective, we use a moment of inertia derived shape analysis to interrogate potential libraries for chemical synthesis. An analysis of known ‘Rule of Five’ compliant drug shapes using this methodology clearly highlights compound libraries that may be reasonably expected, shape wise, to interact with biologically relevant protein active site topography and those that, although being structurally diverse in shape, have little chance of being pharmacologically productive. The use of multicomponent reactions as a means of producing structurally novel, bioactive compounds in a synthetically expeditious manner is also highlighted.</description><subject>Chemistry, Pharmaceutical</subject><subject>Drug Design</subject><subject>Molecular Conformation</subject><issn>1359-6446</issn><issn>1878-5832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU2LFDEQhoMo7u7oPxDpk7duU-l8dDwosrirsOBlPYdOUpnJMNNpk25h_70ZZsCbe6oqeKoK3oeQd0A7oCA_7jufVx9LxyhVHR06CuoFuYZBDa0Yevay9r3QreRcXpGbUvaUAtNCviZXoLTuOfTX5P4xzWmbx3n31No4FvSNS8c5rZNvDtHmMT81HkvcTp-aZYdN2Y0zNinUIU7b0izpxOOXN-RVGA8F317qhvy6-_Z4-719-Hn_4_brQ-s4Y0srguQhuDC6XjEPwKyCwNkgvAdNkQehvR11UHV2IljLtaMSLFXaKsV4vyEfznfnnH6vWBZzjMXh4TBOmNZi5CAoAFXPgj1IwSQXz4KMnh7XsDaEn0GXUykZg5lzPNaADFBzUmL25qzEnJQYOpiqpK69v9xf7RH9v6WLgwp8PgNYc_sTMZviIk4OfczoFuNT_P-Hv3ZNnqY</recordid><startdate>20071101</startdate><enddate>20071101</enddate><creator>Akritopoulou-Zanze, Irini</creator><creator>Metz, James T.</creator><creator>Djuric, Stevan W.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7U5</scope><scope>L7M</scope><scope>7X8</scope></search><sort><creationdate>20071101</creationdate><title>Topography-biased compound library design: the shape of things to come?</title><author>Akritopoulou-Zanze, Irini ; Metz, James T. ; Djuric, Stevan W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-5f64ffcfac372d112b71f4285dd190e4f59dba9f7dd1c5fbb49c061b079b77243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Chemistry, Pharmaceutical</topic><topic>Drug Design</topic><topic>Molecular Conformation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akritopoulou-Zanze, Irini</creatorcontrib><creatorcontrib>Metz, James T.</creatorcontrib><creatorcontrib>Djuric, Stevan W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>MEDLINE - Academic</collection><jtitle>Drug discovery today</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akritopoulou-Zanze, Irini</au><au>Metz, James T.</au><au>Djuric, Stevan W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Topography-biased compound library design: the shape of things to come?</atitle><jtitle>Drug discovery today</jtitle><addtitle>Drug Discov Today</addtitle><date>2007-11-01</date><risdate>2007</risdate><volume>12</volume><issue>21</issue><spage>948</spage><epage>952</epage><pages>948-952</pages><issn>1359-6446</issn><eissn>1878-5832</eissn><abstract>The design and synthesis of quality compound libraries is of critical importance to any pharmaceutical company that relies on high throughput screening efforts for the identification of lead compounds. In this perspective, we use a moment of inertia derived shape analysis to interrogate potential libraries for chemical synthesis. An analysis of known ‘Rule of Five’ compliant drug shapes using this methodology clearly highlights compound libraries that may be reasonably expected, shape wise, to interact with biologically relevant protein active site topography and those that, although being structurally diverse in shape, have little chance of being pharmacologically productive. The use of multicomponent reactions as a means of producing structurally novel, bioactive compounds in a synthetically expeditious manner is also highlighted.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>17993413</pmid><doi>10.1016/j.drudis.2007.08.017</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1359-6446 |
ispartof | Drug discovery today, 2007-11, Vol.12 (21), p.948-952 |
issn | 1359-6446 1878-5832 |
language | eng |
recordid | cdi_proquest_miscellaneous_68501107 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Chemistry, Pharmaceutical Drug Design Molecular Conformation |
title | Topography-biased compound library design: the shape of things to come? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T18%3A08%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Topography-biased%20compound%20library%20design:%20the%20shape%20of%20things%20to%20come?&rft.jtitle=Drug%20discovery%20today&rft.au=Akritopoulou-Zanze,%20Irini&rft.date=2007-11-01&rft.volume=12&rft.issue=21&rft.spage=948&rft.epage=952&rft.pages=948-952&rft.issn=1359-6446&rft.eissn=1878-5832&rft_id=info:doi/10.1016/j.drudis.2007.08.017&rft_dat=%3Cproquest_cross%3E20772441%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20772441&rft_id=info:pmid/17993413&rft_els_id=S1359644607003704&rfr_iscdi=true |